Pulmonary Vascular Disease Evaluation with Magnetic Resonance Angiography

Bradley D. Allen; Mark L. Schiebler; Christopher J. François

doi:10.1016/j.rcl.2020.02.006

Pulmonary Vascular Disease Evaluation with Magnetic Resonance Angiography

Bradley D. Allen^*, Mark L. Schiebler, Christopher J. François

^*Corresponding author for this work

Radiology

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

Pulmonary vascular assessment commonly relies on computed tomography angiography (CTA), but continued advances in magnetic resonance angiography have allowed pulmonary magnetic resonance angiography (pMRA) to become a reasonable alternative to CTA without exposing patients to ionizing radiation. pMRA allows the evaluation of pulmonary vascular anatomy, hemodynamic physiology, lung parenchymal perfusion, and (optionally) right and left ventricular function with a single examination. This article discusses pMRA techniques and artifacts; performance in commonly encountered pulmonary vascular diseases, specifically pulmonary embolism and pulmonary hypertension; and recent advances in both contrast-enhanced and noncontrast pMRA.

Original language	English (US)
Pages (from-to)	707-719
Number of pages	13
Journal	Radiologic clinics of North America
Volume	58
Issue number	4
DOIs	https://doi.org/10.1016/j.rcl.2020.02.006
State	Published - Jul 2020

Keywords

Magnetic resonance angiography
Pulmonary arteries
Pulmonary embolism
Pulmonary hypertension

ASJC Scopus subject areas

Radiology Nuclear Medicine and imaging

Access to Document

10.1016/j.rcl.2020.02.006

Cite this

@article{f86b7120818d49daa54d9ac12471ec5c,

title = "Pulmonary Vascular Disease Evaluation with Magnetic Resonance Angiography",

abstract = "Pulmonary vascular assessment commonly relies on computed tomography angiography (CTA), but continued advances in magnetic resonance angiography have allowed pulmonary magnetic resonance angiography (pMRA) to become a reasonable alternative to CTA without exposing patients to ionizing radiation. pMRA allows the evaluation of pulmonary vascular anatomy, hemodynamic physiology, lung parenchymal perfusion, and (optionally) right and left ventricular function with a single examination. This article discusses pMRA techniques and artifacts; performance in commonly encountered pulmonary vascular diseases, specifically pulmonary embolism and pulmonary hypertension; and recent advances in both contrast-enhanced and noncontrast pMRA.",

keywords = "Magnetic resonance angiography, Pulmonary arteries, Pulmonary embolism, Pulmonary hypertension",

author = "Allen, {Bradley D.} and Schiebler, {Mark L.} and Fran{\c c}ois, {Christopher J.}",

year = "2020",

month = jul,

doi = "10.1016/j.rcl.2020.02.006",

language = "English (US)",

volume = "58",

pages = "707--719",

journal = "Radiologic Clinics of North America",

issn = "0033-8389",

publisher = "W.B. Saunders Ltd",

number = "4",

}

TY - JOUR

T1 - Pulmonary Vascular Disease Evaluation with Magnetic Resonance Angiography

AU - Allen, Bradley D.

AU - Schiebler, Mark L.

AU - François, Christopher J.

PY - 2020/7

Y1 - 2020/7

N2 - Pulmonary vascular assessment commonly relies on computed tomography angiography (CTA), but continued advances in magnetic resonance angiography have allowed pulmonary magnetic resonance angiography (pMRA) to become a reasonable alternative to CTA without exposing patients to ionizing radiation. pMRA allows the evaluation of pulmonary vascular anatomy, hemodynamic physiology, lung parenchymal perfusion, and (optionally) right and left ventricular function with a single examination. This article discusses pMRA techniques and artifacts; performance in commonly encountered pulmonary vascular diseases, specifically pulmonary embolism and pulmonary hypertension; and recent advances in both contrast-enhanced and noncontrast pMRA.

AB - Pulmonary vascular assessment commonly relies on computed tomography angiography (CTA), but continued advances in magnetic resonance angiography have allowed pulmonary magnetic resonance angiography (pMRA) to become a reasonable alternative to CTA without exposing patients to ionizing radiation. pMRA allows the evaluation of pulmonary vascular anatomy, hemodynamic physiology, lung parenchymal perfusion, and (optionally) right and left ventricular function with a single examination. This article discusses pMRA techniques and artifacts; performance in commonly encountered pulmonary vascular diseases, specifically pulmonary embolism and pulmonary hypertension; and recent advances in both contrast-enhanced and noncontrast pMRA.

KW - Magnetic resonance angiography

KW - Pulmonary arteries

KW - Pulmonary embolism

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=85084671545&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85084671545&partnerID=8YFLogxK

U2 - 10.1016/j.rcl.2020.02.006

DO - 10.1016/j.rcl.2020.02.006

M3 - Review article

C2 - 32471539

AN - SCOPUS:85084671545

SN - 0033-8389

VL - 58

SP - 707

EP - 719

JO - Radiologic Clinics of North America

JF - Radiologic Clinics of North America

IS - 4

ER -

Pulmonary Vascular Disease Evaluation with Magnetic Resonance Angiography

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this